经鼻高流量氧疗与胃充气风险:系统综述与荟萃分析
该系统综述与荟萃分析评估经鼻高流量氧疗(HFNO)对胃充气及相关标志物的影响。纳入6项随机试验、5项观察性研究、2项志愿者研究、1项病例系列和2项病例报告,采用GRADE框架评定证据质量。结果显示,与面罩通气相比,HFNO在择期围插管期显著减少胃充气(RR=0.32,95%CI 0.19-0.52,P<.00001,I²=0%),胃窦横截面积无显著差异(MD -0.33 cm²,95%CI -0.72至0.05,P=.09,I²=74%),观察性研究显示胃窦横截面积和胃液量无显著变化,未报告临床显著误吸事件。
要点
- 与面罩通气相比,HFNO在择期围插管期显著降低胃充气风险(RR=0.32)。
- HFNO与面罩通气的胃窦横截面积无显著差异(MD -0.33 cm²)。
- 观察性研究显示HFNO前后胃窦横截面积和胃液量无显著变化。
核心结论
- 中等确定性证据支持HFNO在多数择期和操作情境下对胃充气和胃窦横截面积是安全的。
- 低确定性证据提示HFNO不增加胃体积。
- 高流量和危重症患者中证据有限且质量低至极低,需谨慎。
研究设计与样本
- 系统综述与荟萃分析,纳入6项随机试验、5项观察性研究、2项志愿者研究、1项病例系列和2项病例报告。
- 检索Medline、Embase、Emcare和CINAHL至2025年8月,纳入报告胃充气定性或定量标志物的研究。
- 采用混合方法评价工具评估方法学质量,使用GRADE框架评定证据确定性。
- 对两项或以上研究报告的结局进行荟萃分析。
主要发现
- 4项RCT(n=375)汇总显示,择期围插管期HFNO较面罩通气显著减少胃充气(RR=0.32,95%CI 0.19-0.52,P<.00001,I²=0%),中等确定性。
- 3项RCT(n=318)汇总显示,HFNO与面罩通气的胃窦横截面积无显著差异(MD -0.33 cm²,95%CI -0.72至0.05,P=.09,I²=74%),中等确定性。
- 观察性研究显示,HFNO前后胃窦横截面积无显著增加(MD 0.08 cm²,95%CI -0.29至0.45,P=.67,I²=0%),胃液量无显著变化(MD -0.01 ml/kg,95%CI -0.07至0.06,P=.80,I²=0%),低确定性。
- 非汇总数据提示危重症患者可能增加,但证据确定性极低。
- 单项研究评估微误吸,发现HFNO较面罩通气减少胃食管反流并预防微误吸;所有研究均未报告临床显著误吸事件。
关键数值与推荐
- 择期围插管期HFNO vs 面罩通气:胃充气RR=0.32(95%CI 0.19-0.52),中等确定性。
- 胃窦横截面积:HFNO vs 面罩通气MD -0.33 cm²(95%CI -0.72至0.05),中等确定性。
- HFNO前后胃窦横截面积MD 0.08 cm²(95%CI -0.29至0.45),低确定性。
- HFNO前后胃液量MD -0.01 ml/kg(95%CI -0.07至0.06),低确定性。
临床怎么用
- 在择期围插管期,HFNO可安全使用,胃充气风险低于面罩通气。
- 对危重症患者或高流量HFNO应用时,应警惕胃充气可能,但现有证据质量低。
- HFNO可能减少胃食管反流和微误吸,但需更多研究确认。
局限性
- 高流量和危重症患者中证据有限且质量低至极低。
- 观察性研究主要为干预前后比较,可能存在混杂。
- 需要更大规模多中心试验和稳健观察性研究确认特定情境的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-flow nasal oxygen (HFNO) generates positive airway pressure, raising concerns about gastric insufflation and aspiration risk. Although most studies report minimal or no gastric distension, some suggest significant changes. This systematic review and meta-analysis applied the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to evaluate the effect of HFNO on gastric insufflation and related markers across clinical settings. We searched Medline, Embase, Emcare, and CINAHL through August 2025 for studies reporting qualitative or quantitative markers of gastric insufflation during HFNO use, including comet-tail artifacts, antral cross-sectional area, and gastric volume. Eligible designs included randomized trials, observational and volunteer studies, and case reports. Methodological quality was evaluated using the Mixed Methods Appraisal Tool, and certainty of evidence was rated with GRADE. Meta-analysis was performed for outcomes reported in two or more studies. Six randomized trials, five observational studies, two volunteer studies, one case series, and two case reports were included. Observational studies primarily assessed outcomes before and after HFNO intervention. Pooled analysis of four randomized controlled trials (RCTs; n = 375) showed HFNO significantly reduced gastric insufflation compared with face-mask ventilation during elective peri-intubation (risk ratios [RR] = 0.32; 95% confidence interval [CI], 0.19-0.52; P < .00001; I 2 = 0%), rated moderate-certainty. For antral cross-sectional area, pooled analysis of three RCTs (n = 318) found no significant difference between HFNO and face-mask ventilation (MD -0.33 cm 2 ; 95% CI, -0.72 to 0.05; P = .09; I 2 = 74%), rated moderate-certainty. Observational studies assessing pre- and post-HFNO changes showed no significant increase in antral cross-sectional area (MD 0.08 cm 2 ; 95% CI, -0.29 to 0.45; P = .67; I 2 = 0%) and no significant change in gastric liquid volume (MD -0.01 ml/kg; 95% CI, -0.07 to 0.06; P = .80; I 2 = 0%), both rated low certainty. Nonpooled data suggested possible increases in critically ill patients, but the evidence was of very low certainty. A single study assessing microaspiration found HFNO reduced gastroesophageal reflux and prevented microaspiration compared with face-mask ventilation. No clinically significant aspiration events were reported across studies. Moderate-certainty evidence supports HFNO as safe regarding gastric insufflation and antral cross-sectional area in most elective and procedural contexts. Low-certainty evidence suggests no increase in gastric volume. Caution is warranted due to limited, low-to-very-low-certainty evidence at higher flow rates and among critically ill patients. Larger multicenter trials and robust observational studies are necessary to confirm safety in these settings.
引用
- Thiruvenkatarajan V, Jeyadoss J, Harford P, et al. High-Flow Nasal Oxygen and the Risk of Gastric Insufflation: A Systematic Review and Meta-Analysis Supplemented by Narrative Synthesis. Anesth Analg. 2026. PMID: 41785478. doi:10.1213/ANE.0000000000008005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。